AI Stock Finder
Loading...
Skip to main content
AI Stock Finder · Updated Oct. 14, 2026

West Pharmaceutical Services Inc WST Stock Forecast

AI-powered price prediction and analysis for West Pharmaceutical Services Inc · Alpha · vs marketSwitch to Total

Follow
AI 90-Day Forecast ▼ Exact rating locked
7 Days Sign up free to reveal
30 Days Sign up free to reveal
90 Days Sign up free to reveal
AI Confidence n/a Spearman Correlation

See WST's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.

Price

Price Chart

WST
Fundamentals

Key Statistics

Market Cap$26.17B
P/E Ratio46.3x
P/B Ratio8.75x
Div. Yield0.24%
EPS$7.81
ROE18.9%
Net Margin17.0%
Revenue$3.33B
Current Ratio2.82x
D/E Ratio0.36x
Company

About West Pharmaceutical Services Inc

West Pharmaceutical Services Inc (WST) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry.

Industrial Applications and Services Surgical & Medical Instruments & Apparatus NYSE Large Cap
News

Latest News

Where WST sits on the market map

Industrial Applications and Services · Surgical & Medical Instruments & Apparatus
Explore the map →
Industry Peers

Surgical & Medical Instruments & Apparatus Peers

Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.

CompanyAI SignalMarket CapP/E
WST West Pharmaceutical Services Inc ▼ $26.17B 46.3x
SYK Stryker Corp ▼ $108.38B 29.1x
MMM 3m Co ▼ $83.94B 28.0x
BSX Boston Scientific Corp ▼ $62.77B 17.1x
BDX Becton Dickinson & Co ▼ $51.04B 54.2x
MDLN Medline Inc. ▶ $46.94B –
RMD Resmed Inc ▼ $33.91B 22.3x
DXCM Dexcom Inc ▶ $32.42B 32.4x
SOLV Solventum Corp ▼ $14.69B 10.2x
BAX Baxter International Inc ▶ $12.87B –
PEN Penumbra Inc ▼ $12.61B 78.5x
GMED Globus Medical Inc ▼ $10.25B 19.1x
GKOS Glaukos Corp ▲ $9.76B –
PODD Insulet Corp ▼ $9.58B 25.5x
STVN Stevanato Group S.P.A. ▲ $5.83B –
HAE Haemonetics Corp ▼ $5.54B 57.5x
TFX Teleflex Inc ▼ $5.27B –
MMSI Merit Medical Systems Inc ▼ $5.26B 36.2x
MMED Minimed Group, Inc. ▶ $5.18B –
HTFL Heartflow, Inc. ▲ $4.38B –
ICUI Icu Medical Inc/De ▼ $4.08B –
IRTC Irhythm Holdings, Inc. ▼ $3.55B –
PLSE Pulse Biosciences, Inc. ▲ $3.46B –
ATRC Atricure, Inc. ▶ $2.89B –
UFPT Ufp Technologies Inc ▶ $2.28B 31.5x
INSP Inspire Medical Systems, Inc. ▶ $1.99B 14.7x
LMAT Lemaitre Vascular Inc ▲ $1.86B 28.4x
ATEC Alphatec Holdings, Inc. ▲ $1.67B –
NVCR Novocure Ltd ▲ $1.67B –
KMTS Kestra Medical Technologies, Ltd. ▲ $1.61B –
DRTS Alpha Tau Medical Ltd. ▲ $1.21B –
TNDM Tandem Diabetes Care Inc ▶ $1.16B –
IRMD Iradimed Corp ▲ $1.15B 49.7x
BVS Bioventus Inc. ▶ $1.14B 20.9x
PRCT Procept Biorobotics Corp ▲ $1.09B –
IART Integra Lifesciences Holdings Corp ▼ $1.08B –
AORT Artivion, Inc. ▲ $1.04B –
SIBN Si-Bone, Inc. ▲ $882M –
SGP Spyglass Pharma, Inc. ▲ $800M –
BBNX Beta Bionics, Inc. ▲ $796M –
MDXG Mimedx Group, Inc. ▲ $684M –
KIDS Orthopediatrics Corp ▶ $573M –
SSII Ss Innovations International, Inc. ▲ $511M –
TCMD Tactile Systems Technology Inc ▲ $505M 20.3x
BWAY Brainsway Ltd. ▲ $467M –
SGHT Sight Sciences, Inc. ▲ $462M –
CERS Cerus Corp ▲ $455M –
ANGO Angiodynamics Inc ▲ $451M –
NPCE Neuropace Inc ▶ $435M –
RCEL Avita Medical, Inc. ▲ $413M –
CARL Carlsmed, Inc. ▲ $395M –
OFIX Orthofix Medical Inc. ▼ $377M –
EMBC Embecta Corp. ▲ $351M 4.0x
OBIO Orchestra Biomed Holdings, Inc. ▲ $344M –
CLPT Clearpoint Neuro, Inc. ▲ $299M –
MOBI Mobia Medical, Inc. ▲ $283M –
ANIK Anika Therapeutics, Inc. ▲ $275M –
TMCI Treace Medical Concepts, Inc. ▲ $267M –
OSUR Orasure Technologies Inc ▲ $263M –
PROF Profound Medical Corp. ▲ $256M –
FAQ

FAQ

Is West Pharmaceutical Services Inc a good stock to buy?

Our AI analyzes West Pharmaceutical Services Inc daily. Check the signal above for the latest recommendation. Always do your own research before investing.

How accurate are West Pharmaceutical Services Inc predictions?

A per-ticker accuracy statistic for WST is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are forecasts updated?

West Pharmaceutical Services Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.

Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions

Sign Up Free

Looking for a deeper analysis of West Pharmaceutical Services Inc? View full institutional-grade analysis on Intratio →

AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.